41
non
-
musculoskeletal diseases. Recent studies showed that ESWT is effective in chronic dia-
betic foot ulcers [
126
,
127
] and ischemic heart disease [
128
,
129
].
In conclusion, ESWT is a new non
-
invasive therapeutic modality with effectiveness, con-
venience and safety. ESWT has the potential of replacing surgery in many orthopedic disor-
ders without the surgical risks. The complication rates are low and negligible. The exact
mechanism of shockwave therapy remains unknown. In animal experiments, ESWT induc-
es a cascade of biological responses and molecular changes including the ingrowth of neo-
vascularization and up
-
regulation of angiogenetic growth factors leading to the improve-
ment in blood supply and tissue regeneration. There is a great potential for translational re-
search and development in the armamentarium of extracorporeal shockwave technology.
Declarations
Competing interests
The author declared that he did not receive any honoraria or consultancy fee in writing this
manuscript. No benefit was received or will be received directly or indirectly from a com-
mercial party related to the performance of this study. The author has served as the member
of scientific advisory committee of Sanuwave (Alpharetta, GA).
Authors' contributions
C
-
JW participated in the study with the responsibility in protocol drafting, reference search,
data collection and data analysis, manuscript writing and final proof of the manuscript.
References
1. Buch M, Knorr U, Fleming L, Theodore G, Amendola A, Bachmann C, Zingas C, Siebert WE: Extracorpo-
real shockwave therapy in symptomatic heel spurs. An overview. Orthopade. 2002, 31 (7): 637
-
44.
10.1007/s00132
-
002
-
0323
-
z.
2. Perez M, Weiner R, Gilley JC: Extracorporeal shock wave therapy for plantar fasciitis. Clin Podi Med
Surg. 2003, 20 (2): 323
-
34. 10.1016/S0891
-
8422(03)00002
-
8.
3. Roehrig GJ, Baumhauer J, DiGiovanni BF, Flemister AS: The role of extracorporeal shock wave on plan-
tar fasciitis. Foot Ankle Clin. 2005, 10 (4): 699
-
712. 10.1016/j.fcl.2005.06.002.
4. Strash WW, Perez RR: Extracorporeal shockwave therapy for chronic proximal plantar fasciitis. Clin
Podi Med Surg. 2002, 19 (4): 467
-
76. 10.1016/S0891
-
8422(02)00016
-
2.
5. Thomson CE, Crawford F, Murray GD: The effectiveness of extra corporeal shock wave therapy for
plantar heel pain: a systematic review and meta
-
analysis. BMC Musculoskelet Disord. 2005, 6: 19
-
10.1186/1471
-
2474
-
6
-
19.
6. Wilner JM, Strash WW: Extracorporeal shockwave therapy for plantar fasciitis and other musculoskel-
etal conditions utilizing the Ossatron
-
an update. Clin Podi Med Surg. 2004, 21 (3): 441
-
7.
j.cpm.2004.03.002.
7. Buchbinder R, Green SE, Youd JM, Assendelft WJ, Barnsley L, Smidt N: Systematic review of the effica-
cy and safety of shock wave therapy for lateral elbow pain. J Rheum. 2006, 33 (7): 1351
-
63.
8. Rompe JD, Theis C, Maffulli N: Shock wave treatment for tennis elbow. Orthopade. 2005, 34 (6): 567
-
70. 10.1007/s00132
-
005
-
0805
-
x.
9. Rompe JD, Maffulli N: Repetitive shock wave therapy for lateral elbow tendinopathy (tennis elbow): a
systematic and qualitative analysis. Br Med Bulletin. 2007, 83: 355
-
78. 10.1093/bmb/ldm019.
10. Stasinopoulos D, Johnson MI: Effectiveness of extracorporeal shock wave therapy for tennis elbow
(lateral epicondylitis). Br J Sports Med. 2005, 39 (3): 132
-
6. 10.1136/bjsm.2004.015545.
11. Mouzopoulos G, Stamatakos M, Mouzopoulos D, Tzurbakis M: Extracorporeal shock wave treatment
for shoulder calcific tendonitis: a systematic review. SSkeletal Radiol. 2007, 36 (9): 803
-
11. 10.1007/
s00256
-
007
-
0297
-
3.
Summary of Contents for VIPP
Page 1: ...CellSonic VIPP Owner s Manual ...
Page 2: ...2 ...
Page 14: ...14 ...
Page 29: ...29 PATIE NT TREATMENT PROTOCOL WORKSHEET 1 ...
Page 49: ...49 ...
Page 50: ...50 ...